Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients

OBJECTIVES: Hydroxychloroquine is an antimalarial agent that has been used in systemic lupus erythematosus and rheumatoid arthritis treatment for many years. Recently, novel mechanisms of action have been proposed, thereby broadening the therapeutic perspective of this medication. The purpose of thi...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: da Silva, Juliana Cruz, Mariz, Henrique Ataide, da Rocha Júnior, Laurindo Ferreira, Santana de Oliveira, Priscilla Stela, Dantas, Andrea Tavares, Duarte, Angela Luzia Branco Pinto, da Rocha Pitta, Ivan, Galdino, Suely Lins, da Rocha Pitta, Maira Galdino
Natura: Artigo
Lingua:Inglês
Pubblicazione: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2013
Soggetti:
Clinical Science
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3674253/
https://ncbi.nlm.nih.gov/pubmed/23778483
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6061/clinics/2013(06)07
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi